Study of Lenacapavir, Teropavimab, and Zinlirvimab in Virologically Suppressed Adults With HIV-1 on Stable Oral Treatment Regimens

Clinical trial NCT07683000 · RECRUITING

Trial details

NCT number: NCT07683000
Sponsor: Gilead Sciences
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

HIV-1-infection

Start date: 2026-07-14
Primary completion: 2029-03-01
Enrollment: 590

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.